The Food and Drug Administration (FDA) on Friday scheduled public meeting to review COVID-19 vaccines for the youngest children in the U.S.
company said the shot was about 51% effective against the virus for kids under 2 years old and about 37% effective in kids ages 2 to 5.
It added that similar requests are underway with international regulatory authorities, noting that the requests are based on a 25-microgram two-dose primary series of the vaccine. "We are proud to share that we have initiated our EUA submission for authorization for our COVID-19 vaccine for young children," Moderna CEO Stéphane Bancel said in a statement."We believe mRNA-1273 will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against COVID-19 and will be especially welcomed by parents and caregivers.
Right now, only children ages 5 or older can be vaccinated in the U.S., using rival Pfizer’s vaccine.Pfizer is also expected to announce if three of its even smaller-dose shots work for the youngest children. Right now, only children ages 5 or older can be vaccinated in the U.S., using rival Pfizer’s vaccine.Julia Musto is a reporter for Fox News Digital. You can find her on Twitter at @JuliaElenaMusto.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA sets June dates to meet on COVID vaccine for young kidsThe agency’s advisory committee has been asked to convene to make recommendations on Moderna and Pfizer’s vaccines for the youngest age group.
Read more »
FDA Sets June Meetings on COVID Vaccines for Youngest KidsThe meeting announcement follows months of frustration from families impatient for a chance to vaccinate their little children, along with complaints from politicians bemoaning the slow pace of the process.
Read more »
FDA to review COVID vaccines for youngest kids in JuneThe agency set tentative dates in June to publicly review the vaccines, typically the final step before authorizing the shots.
Read more »
FDA sets June meetings on COVID vaccines for youngest kidsThe FDA said it plans to convene its outside panel of vaccine experts on June 8, 21 and 22 to review applications from Moderna and Pfizer for child vaccines.
Read more »
COVID Vaccines for Kids Under 5 Could be Available in June, FDA Official SaysAn FDA official has said that coronavirus vaccines for children under the age of 5 will be considered — and likely approved — as soon as June.
Read more »
FDA could authorize COVID vaccine for children 5 and under, and Novavax vaccine, this JuneThe Food and Drug Administration released a tentative schedule of meetings for its outside vaccine advisers in June on vaccines for the youngest children.
Read more »